ZA96454B - Cells for the production of recombinant adenoviruses - Google Patents

Cells for the production of recombinant adenoviruses

Info

Publication number
ZA96454B
ZA96454B ZA96454A ZA96454A ZA96454B ZA 96454 B ZA96454 B ZA 96454B ZA 96454 A ZA96454 A ZA 96454A ZA 96454 A ZA96454 A ZA 96454A ZA 96454 B ZA96454 B ZA 96454B
Authority
ZA
South Africa
Prior art keywords
cells
production
recombinant adenoviruses
adenoviruses
recombinant
Prior art date
Application number
ZA96454A
Inventor
Emmanuelle Vigne
Michel Perricaudet
Jean-Francois Dedieu
Cecile Orsini
Patrice Yeh
Martine Latta-Mahieu
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA96454B publication Critical patent/ZA96454B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361Methods of inactivation or attenuation
    • C12N2710/10362Methods of inactivation or attenuation by genetic engineering
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA96454A 1995-01-20 1996-01-19 Cells for the production of recombinant adenoviruses ZA96454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500747A FR2729674B1 (en) 1995-01-20 1995-01-20 CELLS FOR THE PRODUCTION OF RECOMBINANT ADENOVIRUSES

Publications (1)

Publication Number Publication Date
ZA96454B true ZA96454B (en) 1996-08-07

Family

ID=9475409

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96454A ZA96454B (en) 1995-01-20 1996-01-19 Cells for the production of recombinant adenoviruses

Country Status (2)

Country Link
FR (1) FR2729674B1 (en)
ZA (1) ZA96454B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5253998A (en) 1996-11-13 1998-06-03 Board Of Regents, The University Of Texas System Diminishing viral gene expression by promoter replacement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0673431A1 (en) * 1992-12-03 1995-09-27 Genzyme Corporation Gene therapy for cystic fibrosis
FR2705686B1 (en) * 1993-05-28 1995-08-18 Transgene Sa New defective adenoviruses and corresponding complementation lines.
ES2310924T3 (en) * 1993-07-13 2009-01-16 Centelion DEFECTIVE ADENOVIRAL VECTORS AND USE IN GENE THERAPY.
FR2707664B1 (en) * 1993-07-13 1995-09-29 Centre Nat Rech Scient Viral vectors and use in gene therapy.

Also Published As

Publication number Publication date
FR2729674A1 (en) 1996-07-26
FR2729674B1 (en) 1997-04-11

Similar Documents

Publication Publication Date Title
AU4544396A (en) Cells for the production of recombinant adenoviruses
IL109008A0 (en) Immunoassy for determination of cells
IL125126A0 (en) Electroconversion cell
AU4370596A (en) Novel hedgehog-derived polypeptides
AU4930399A (en) Novel Polypeptide
AU4271793A (en) Novel polypeptide
GB9502830D0 (en) Regulation of polypeptide production in cells
ZA96454B (en) Cells for the production of recombinant adenoviruses
ZA975823B (en) Process for the production of recombinant adenoviruses.
GB2302839B (en) Improvements in the manufacture of roof tiles
AU1184800A (en) Novel polypeptide
GB9306957D0 (en) Brick manufacture
AU6476398A (en) Novel peptides
GB9619633D0 (en) Recombinant plant cells
GB9621492D0 (en) Novel cell surface protein compounds
AU5276196A (en) Method for the continuous preparation of recombinant proteinsfrom cell cultures
EP0873349A4 (en) Endothelial-monocyte activating polypeptide iii
AU4766793A (en) Dewatering arrangement
FR2738575B1 (en) CELLS FOR THE PRODUCTION OF RECOMBINANT ADENOVIRUSES
GB9514835D0 (en) Polypeptide
GB9514580D0 (en) Polypeptide
AU3675895A (en) Floating roof
GB9515488D0 (en) Recombinant proteins their production & use
HU9503358D0 (en) Procedure for making vaselpnes with high purity
GB9508129D0 (en) Cell modification